Aditxt Therapeutics
Loma Linda · Founded 2017
About Aditxt Therapeutics
Aditx Therapeutics is a biotechnology company developing a novel nucleic acid-based technology to selectively suppress immune cells involved in the rejection of transplanted tissues and organs. The company was founded in 2017 by Amro Albanna and is based in Loma Linda, California, United States.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $79.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2024)
- Ticker: nasdaq:ADTX
- Website: aditxt.com
- Phone: (909) 488-0844
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aditxt-therapeutics-143442 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.